SlideShare a Scribd company logo
RCR guidelines for Management of
Unscheduled Tx interruptions
RANJITH C P
Introduction
 Radical courses of radiotherapy treatment should not be interrupted
 Interruptions increases the risk of local recurrence
 Mathematical modelling of the data from various studies suggests
that, unscheduled gap of one day- reduction of local control by 1.4%.
RCR guidelines
 Which categories of patients are at risk of loss of tumour control/cure
rates from unscheduled interruptions?
 Causes of unscheduled interruptions ?
 How interruptions can be prevented ?
 How to manage ?
Loss of TCP per day
Loss of TCP per day
Loss of TCP per day
Mostly affecting tumour types
 Head and neck squamous cell carcinomas (HNSCC)
 Cancers of the cervix
 Cancers of the lung: a) non-small cell (NSCLC) and b) small cell
(SCLC) Cancers of the oesophagus
 Medulloblastoma and primitive neuroectodermal tumours
(PNET).
Category 1( 2days)
 Squamous cell carcinoma of the head and neck region(grade B
recommendation on level 2++evidence)
 Non-small cell carcinoma of lung (NSCLC)(grade C
recommendation)
 Squamous cell carcinoma of the cervix(grade D recommendation)
 Small cell carcinoma of lung(chemo-radiotherapy) (grade D
recommendation).
 Squamous cell carcinoma oesophagus (grade D recommendation)
 Squamous cell carcinoma skin, vagina or vulva (grade D
recommendation)
 Adenocarcinoma oesophagus (grade D recommendation)
 Medulloblastoma and primitive neuroectodermal tumours (PNET)
(grade B recommendation on level 2++ evidence)
Category 2
 Patients with squamous cell carcinoma of the anus, treated
with chemo- radiotherapy – less than 7 days
 Patients with adenocarcinoma of the breast, receiving
postoperative therapy over five weeks or more should not
have their radical treatment prolonged by more than Five
days (grade C recommendation).
 There is no evidence about prolongation of shorter (three-
week) courses of radiotherapy for breast cancer.
 Patients with transitional cell carcinoma of the bladder
(grade D recommendation).
 Patients with carcinoma of the prostate (grade D
recommendation)
Category3
 These are patients being treated with palliative intent. Overall
time is less critical in achieving the desired palliative outcomes.
 Should be less than 7 days
Causes of Tx interruptions
Planning the overall service
 Working across bank holidays to prevent interruptions to patient
treatment.
 The impact of machine servicing and quality assurance on the
continuity of patients’ treatment must be carefully considered in
scheduling these activities.
 The provision of adequate resources in terms of machines, staff
and training must be the subject of long-term planning.
 Patient transport must be organised to ensure continuity of
treatment.
Management of unscheduled
interruptions
 Machine breakdown, staff or patient illness.
 Transfer all patients to a matched linear accelerator.
 Treated twice daily, with a minimum of six hours
 Twice-daily towards the end of a week to allow more repair of
sub-lethal damage to normal tissue.
 Use of biologically equivalent dose (BED) calculations.
 The addition of extra treatment fractions where compensation
cannot be achieved within the original overall planned time.
Does the length of the interruption
matter?
 A relative loss of local control ranging from 3 to 25% (median
14%) arises when a treatment prolongation of one week
occur.
Does the length of the interruption
matter?
 Brachytherapy and external beam - SCC of the tonsil -
beyond 42 days significantly reduced local control rates
 For locally advanced cervical cancer - should not exceed
56 days for squamous carcinoma
 prolongation of more than seven days for those with
carcinoma of the breast receiving postoperative
irradiation over five weeks results in an increased risk of
local recurrence
Does the timing of the interruption
matter?
 Accelerated repopulation which is apparent in some tumour
types after 21- 28 days of radiation treatment alters the K-
factor
 Correction for interruptions arising later in a long course of
therapy -number of large fractions over a short period - long-
term late effects.
 interruption on a Monday or Friday which lengthens the
weekend break by 33%, may have a more serious adverse effect
than an interruption mid-week
Management of potential prolongation
of a treatment schedule
 Machine and staff availability- beam matched machines
 Public holidays- ideally treat category 1 patients on public holidays
 Transport problems
 Medical problems- proactive support from appropriate healthcare
professionals, experienced radiographers, nursing staff, dietitians and
so on
 Written guidance to patients at the start of treatment facilitates the
recognition and management of early reactions.
 Patient specific reminders- Categories of Pt at Linac, Communication
 Patients must be made aware of the importance of daily attendance
for treatment, and this should be clearly stated in writing before
treatment starts
Management of Individual patients
 Those individual patients with relatively resistant tumours are
probably fail radiotherapy anyway
 the dose-response curve is relatively flat and the adverse effect of
prolonged treatment time is of little significance
 Patients with sensitive tumours are those who are likely to benefit
from radiotherapy
 The patients who will be most disadvantaged by prolongation of
treatment without compensation will be those whose probability
of local control is around 50%.
LQ model based iso effective dose
calculations.
BED =nd* (1 + d/(α/β)) - (ln2 (T - Tk)) / αTp
 Tp- Effective Doubling time
 Tk- kick of time (tumour repopulation) usually 21-28 days
Normal tissue
Tumour values
K values- extra dose/day to keep same
TCP
K value
Gap correction method using BED
 Determine remaining no of fractions and dose
 Try to Treat patient on weekend days and two fractions daily to
finish within the total treatment days planned
 Two fraction per day slightly increase late normal tissue toxicity
due to incomplete repair.
Method of calculation
Example 1.
 Loss of all of the third week (five fractions) of a treatment
schedule of 70 Gy/35 fractions/47 days. 7 weeks
 10# treated, 25# remaining.
 26 days remaining including weekends.
 Treat on next 3 Saturdays and bi-fraction on last two Friday can
finish the Tx within the prescribed time.
 If bi-fraction treated then at least 6 h gap maintained.
Example 2
 Loss of all of the sixth week (five fractions) of a treatment
schedule of 70 Gy/35 fractions/46 days
 25# treated, 10 remaining
 Bi-fraction on 6th weekend Saturday
 Bi-fraction on last 5 alternate days(Monday-Wednesday and
Friday)
 The overall treatment time remaining same, with some
incomplete repair of normal tissue(bi-fraction)
 Example 3
 Loss of all of the seventh week (five fractions) of a treatment
schedule of 70 Gy/35 fractions/46 days
 25# treated. 0 days remaining
 Normal tissue BED as prescribed
Normal BED =
Example 3
 Delivered BED before gap
 Remaining Normal tissue BED =100-116.7=16.6Gy BED
 The tumour BED for prescribed schedule (k=0.9Gy/day, Tdelay-28 days)
Example 3
 Continue Tx on next 5 days of next week(8th week)
 The loss of BED due to repopulation is 7*0.9Gy/day=6.3Gy BED.
 So the tumour BED fall of 9%, the Normal tissue BED same.
 To make Tumour BED the same as prescribed then,
 BED10 (pre-gap) + BED10 (post-gap) – tumor repopulation factor =
prescribed BED10
 Now total Tx days become 51 days.
 New dose per fraction is 2.62Gy.
 But the normal tissue BED become
6.7% excess than scheduled. So now make a compromise between TCP
and NTCP
by trail and error find a dose per fraction, ex: d=2.3Gy then Tumour BED
become 3.5% lower and normal tissue BED 3.1% higher.
Conclusions
Conclusion
 Try to avoid unscheduled gap
 Make Departmental protocol to reduce the interruption in Tx
 Make the patient category list
 Educate patient ‘the importance of daily attendance for Tx’
 Use BED based formalism to make calculation by using proper alpha/beta and
K values.
 The gap correction will be effective once we implement the methods just
after the gap occurs.

More Related Content

What's hot

Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Kiran Ramakrishna
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
Sasikumar Sambasivam
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Rahim Gohar
 
EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)
Nik Noor Ashikin Nik Ab Razak
 
linac QA.pptx
linac QA.pptxlinac QA.pptx
linac QA.pptx
Rupesh42492
 
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
SGRT Community
 
Evaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planningEvaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planning
Amin Amin
 
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
Kiran Ramakrishna
 
Interstitial BT Principles
Interstitial BT PrinciplesInterstitial BT Principles
Interstitial BT Principles
Yamini Baviskar
 
4dct (2012)
4dct (2012)4dct (2012)
4dct (2012)
Parminder S. Basran
 
Radiotheray transition from 2D to 3D Conformal radiotherapy(3D-CRT)
Radiotheray transition  from 2D to 3D Conformal  radiotherapy(3D-CRT)Radiotheray transition  from 2D to 3D Conformal  radiotherapy(3D-CRT)
Radiotheray transition from 2D to 3D Conformal radiotherapy(3D-CRT)
Gebrekirstos Hagos Gebrekirstos, MD
 
Icru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniationIcru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniation
althaf jouhar
 
ICRU CONCEPT
ICRU CONCEPTICRU CONCEPT
ICRU CONCEPT
Kanhu Charan
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
basilpaulsunny
 
Imrt Treatment Planning And Dosimetry
Imrt Treatment Planning And DosimetryImrt Treatment Planning And Dosimetry
Imrt Treatment Planning And Dosimetryfondas vakalis
 
Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)
Nik Noor Ashikin Nik Ab Razak
 
Multileaf Collimator
Multileaf CollimatorMultileaf Collimator
Multileaf Collimator
Vinay Desai
 
Image Guided Radiotherapy
Image Guided RadiotherapyImage Guided Radiotherapy
Image Guided Radiotherapy
Gemelli Advanced Radiation Therapy
 
Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]
Upasna Saxena
 
RADIOTHERAPY CALCULATION
RADIOTHERAPY CALCULATIONRADIOTHERAPY CALCULATION
RADIOTHERAPY CALCULATION
Nik Noor Ashikin Nik Ab Razak
 

What's hot (20)

Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
 
EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)
 
linac QA.pptx
linac QA.pptxlinac QA.pptx
linac QA.pptx
 
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
Surface Guided Radiotherapy for Accuracy, Volume Reduction, Real time Trackin...
 
Evaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planningEvaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planning
 
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
 
Interstitial BT Principles
Interstitial BT PrinciplesInterstitial BT Principles
Interstitial BT Principles
 
4dct (2012)
4dct (2012)4dct (2012)
4dct (2012)
 
Radiotheray transition from 2D to 3D Conformal radiotherapy(3D-CRT)
Radiotheray transition  from 2D to 3D Conformal  radiotherapy(3D-CRT)Radiotheray transition  from 2D to 3D Conformal  radiotherapy(3D-CRT)
Radiotheray transition from 2D to 3D Conformal radiotherapy(3D-CRT)
 
Icru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniationIcru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniation
 
ICRU CONCEPT
ICRU CONCEPTICRU CONCEPT
ICRU CONCEPT
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
 
Imrt Treatment Planning And Dosimetry
Imrt Treatment Planning And DosimetryImrt Treatment Planning And Dosimetry
Imrt Treatment Planning And Dosimetry
 
Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)
 
Multileaf Collimator
Multileaf CollimatorMultileaf Collimator
Multileaf Collimator
 
Image Guided Radiotherapy
Image Guided RadiotherapyImage Guided Radiotherapy
Image Guided Radiotherapy
 
Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]
 
RADIOTHERAPY CALCULATION
RADIOTHERAPY CALCULATIONRADIOTHERAPY CALCULATION
RADIOTHERAPY CALCULATION
 

Similar to Treatment gap correction methods using bed formalism, radiobiology

Unscheduled rt interruptions
Unscheduled rt interruptionsUnscheduled rt interruptions
Unscheduled rt interruptions
HEBAGOMAA1984
 
Sant Gallent y ESMO 2019
Sant Gallent y ESMO 2019Sant Gallent y ESMO 2019
Sant Gallent y ESMO 2019
Jornadas HM Hospitales
 
management of advanced cervical cancer [Autosaved].pptx
management of advanced cervical cancer [Autosaved].pptxmanagement of advanced cervical cancer [Autosaved].pptx
management of advanced cervical cancer [Autosaved].pptx
SonyNanda2
 
Treatment Of Potentially Resectable Pancreatic Cancer
Treatment Of Potentially Resectable Pancreatic CancerTreatment Of Potentially Resectable Pancreatic Cancer
Treatment Of Potentially Resectable Pancreatic Cancerfondas vakalis
 
Approach towards reirradiation
Approach towards reirradiationApproach towards reirradiation
Approach towards reirradiation
Kanhu Charan
 
New techniques in breast radiotherapy
New techniques in breast radiotherapyNew techniques in breast radiotherapy
New techniques in breast radiotherapyfondas vakalis
 
Cervix_NCI_Gaffney.ppt
Cervix_NCI_Gaffney.pptCervix_NCI_Gaffney.ppt
Cervix_NCI_Gaffney.ppt
MsccMohamed
 
1701 ahnyc imrt lung
1701 ahnyc imrt lung1701 ahnyc imrt lung
1701 ahnyc imrt lung
Yong Chan Ahn
 
Liver
LiverLiver
Pyriform sinus tumours principles of management
Pyriform sinus tumours principles of managementPyriform sinus tumours principles of management
Pyriform sinus tumours principles of management
Md Roohia
 
Tumor board locally advanced rectal cancer
Tumor board locally advanced rectal cancerTumor board locally advanced rectal cancer
Tumor board locally advanced rectal cancerRanjita Pallavi
 
Recent advances in Glioblastoma Multiforme Management
Recent advances in Glioblastoma Multiforme ManagementRecent advances in Glioblastoma Multiforme Management
Recent advances in Glioblastoma Multiforme Management
Rajesh Balakrishnan
 
Vakalis new techniques in breast radiotherapy
Vakalis new techniques in breast radiotherapyVakalis new techniques in breast radiotherapy
Vakalis new techniques in breast radiotherapyfondas vakalis
 
FAST FORWARD ARTICLE
FAST FORWARD ARTICLEFAST FORWARD ARTICLE
FAST FORWARD ARTICLE
Kanhu Charan
 
Radiobiology of Altered Fractionation-1.pptx
Radiobiology of Altered  Fractionation-1.pptxRadiobiology of Altered  Fractionation-1.pptx
Radiobiology of Altered Fractionation-1.pptx
Gopireddysaisunayana
 
Hypofractionation in hnc
Hypofractionation in hncHypofractionation in hnc
Hypofractionation in hnc
Ashutosh Mukherji
 
Esophageal cancer-role of RT
Esophageal cancer-role of RTEsophageal cancer-role of RT
Esophageal cancer-role of RTBharti Devnani
 
hypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptxhypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptx
svmmcradonco1
 

Similar to Treatment gap correction methods using bed formalism, radiobiology (20)

Unscheduled rt interruptions
Unscheduled rt interruptionsUnscheduled rt interruptions
Unscheduled rt interruptions
 
Sant Gallent y ESMO 2019
Sant Gallent y ESMO 2019Sant Gallent y ESMO 2019
Sant Gallent y ESMO 2019
 
management of advanced cervical cancer [Autosaved].pptx
management of advanced cervical cancer [Autosaved].pptxmanagement of advanced cervical cancer [Autosaved].pptx
management of advanced cervical cancer [Autosaved].pptx
 
Treatment Of Potentially Resectable Pancreatic Cancer
Treatment Of Potentially Resectable Pancreatic CancerTreatment Of Potentially Resectable Pancreatic Cancer
Treatment Of Potentially Resectable Pancreatic Cancer
 
Approach towards reirradiation
Approach towards reirradiationApproach towards reirradiation
Approach towards reirradiation
 
10 may sbrt
10 may sbrt10 may sbrt
10 may sbrt
 
New techniques in breast radiotherapy
New techniques in breast radiotherapyNew techniques in breast radiotherapy
New techniques in breast radiotherapy
 
BALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
BALKAN MCO 2011 - E. Vrdoljak - RadiotherapyBALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
BALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
 
Cervix_NCI_Gaffney.ppt
Cervix_NCI_Gaffney.pptCervix_NCI_Gaffney.ppt
Cervix_NCI_Gaffney.ppt
 
1701 ahnyc imrt lung
1701 ahnyc imrt lung1701 ahnyc imrt lung
1701 ahnyc imrt lung
 
Liver
LiverLiver
Liver
 
Pyriform sinus tumours principles of management
Pyriform sinus tumours principles of managementPyriform sinus tumours principles of management
Pyriform sinus tumours principles of management
 
Tumor board locally advanced rectal cancer
Tumor board locally advanced rectal cancerTumor board locally advanced rectal cancer
Tumor board locally advanced rectal cancer
 
Recent advances in Glioblastoma Multiforme Management
Recent advances in Glioblastoma Multiforme ManagementRecent advances in Glioblastoma Multiforme Management
Recent advances in Glioblastoma Multiforme Management
 
Vakalis new techniques in breast radiotherapy
Vakalis new techniques in breast radiotherapyVakalis new techniques in breast radiotherapy
Vakalis new techniques in breast radiotherapy
 
FAST FORWARD ARTICLE
FAST FORWARD ARTICLEFAST FORWARD ARTICLE
FAST FORWARD ARTICLE
 
Radiobiology of Altered Fractionation-1.pptx
Radiobiology of Altered  Fractionation-1.pptxRadiobiology of Altered  Fractionation-1.pptx
Radiobiology of Altered Fractionation-1.pptx
 
Hypofractionation in hnc
Hypofractionation in hncHypofractionation in hnc
Hypofractionation in hnc
 
Esophageal cancer-role of RT
Esophageal cancer-role of RTEsophageal cancer-role of RT
Esophageal cancer-role of RT
 
hypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptxhypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptx
 

Recently uploaded

Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
salisonsalim1
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
blessyjannu21
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
fahmyahmed789
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptxThe Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
Global Travel Clinics
 
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
The Lifesciences Magazine
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 

Recently uploaded (20)

Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
Cardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing studentCardiac Arrhythmias (2).pdf for nursing student
Cardiac Arrhythmias (2).pdf for nursing student
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptxThe Importance of COVID-19 PCR Tests for Travel in 2024.pptx
The Importance of COVID-19 PCR Tests for Travel in 2024.pptx
 
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 

Treatment gap correction methods using bed formalism, radiobiology

  • 1. RCR guidelines for Management of Unscheduled Tx interruptions RANJITH C P
  • 2. Introduction  Radical courses of radiotherapy treatment should not be interrupted  Interruptions increases the risk of local recurrence  Mathematical modelling of the data from various studies suggests that, unscheduled gap of one day- reduction of local control by 1.4%.
  • 3.
  • 4.
  • 5. RCR guidelines  Which categories of patients are at risk of loss of tumour control/cure rates from unscheduled interruptions?  Causes of unscheduled interruptions ?  How interruptions can be prevented ?  How to manage ?
  • 6. Loss of TCP per day
  • 7. Loss of TCP per day
  • 8. Loss of TCP per day
  • 9. Mostly affecting tumour types  Head and neck squamous cell carcinomas (HNSCC)  Cancers of the cervix  Cancers of the lung: a) non-small cell (NSCLC) and b) small cell (SCLC) Cancers of the oesophagus  Medulloblastoma and primitive neuroectodermal tumours (PNET).
  • 10. Category 1( 2days)  Squamous cell carcinoma of the head and neck region(grade B recommendation on level 2++evidence)  Non-small cell carcinoma of lung (NSCLC)(grade C recommendation)  Squamous cell carcinoma of the cervix(grade D recommendation)  Small cell carcinoma of lung(chemo-radiotherapy) (grade D recommendation).  Squamous cell carcinoma oesophagus (grade D recommendation)  Squamous cell carcinoma skin, vagina or vulva (grade D recommendation)  Adenocarcinoma oesophagus (grade D recommendation)  Medulloblastoma and primitive neuroectodermal tumours (PNET) (grade B recommendation on level 2++ evidence)
  • 11. Category 2  Patients with squamous cell carcinoma of the anus, treated with chemo- radiotherapy – less than 7 days  Patients with adenocarcinoma of the breast, receiving postoperative therapy over five weeks or more should not have their radical treatment prolonged by more than Five days (grade C recommendation).  There is no evidence about prolongation of shorter (three- week) courses of radiotherapy for breast cancer.  Patients with transitional cell carcinoma of the bladder (grade D recommendation).  Patients with carcinoma of the prostate (grade D recommendation)
  • 12. Category3  These are patients being treated with palliative intent. Overall time is less critical in achieving the desired palliative outcomes.  Should be less than 7 days
  • 13. Causes of Tx interruptions
  • 14. Planning the overall service  Working across bank holidays to prevent interruptions to patient treatment.  The impact of machine servicing and quality assurance on the continuity of patients’ treatment must be carefully considered in scheduling these activities.  The provision of adequate resources in terms of machines, staff and training must be the subject of long-term planning.  Patient transport must be organised to ensure continuity of treatment.
  • 15. Management of unscheduled interruptions  Machine breakdown, staff or patient illness.  Transfer all patients to a matched linear accelerator.  Treated twice daily, with a minimum of six hours  Twice-daily towards the end of a week to allow more repair of sub-lethal damage to normal tissue.  Use of biologically equivalent dose (BED) calculations.  The addition of extra treatment fractions where compensation cannot be achieved within the original overall planned time.
  • 16. Does the length of the interruption matter?  A relative loss of local control ranging from 3 to 25% (median 14%) arises when a treatment prolongation of one week occur.
  • 17. Does the length of the interruption matter?  Brachytherapy and external beam - SCC of the tonsil - beyond 42 days significantly reduced local control rates  For locally advanced cervical cancer - should not exceed 56 days for squamous carcinoma  prolongation of more than seven days for those with carcinoma of the breast receiving postoperative irradiation over five weeks results in an increased risk of local recurrence
  • 18. Does the timing of the interruption matter?  Accelerated repopulation which is apparent in some tumour types after 21- 28 days of radiation treatment alters the K- factor  Correction for interruptions arising later in a long course of therapy -number of large fractions over a short period - long- term late effects.  interruption on a Monday or Friday which lengthens the weekend break by 33%, may have a more serious adverse effect than an interruption mid-week
  • 19. Management of potential prolongation of a treatment schedule  Machine and staff availability- beam matched machines  Public holidays- ideally treat category 1 patients on public holidays  Transport problems  Medical problems- proactive support from appropriate healthcare professionals, experienced radiographers, nursing staff, dietitians and so on  Written guidance to patients at the start of treatment facilitates the recognition and management of early reactions.  Patient specific reminders- Categories of Pt at Linac, Communication  Patients must be made aware of the importance of daily attendance for treatment, and this should be clearly stated in writing before treatment starts
  • 20. Management of Individual patients  Those individual patients with relatively resistant tumours are probably fail radiotherapy anyway  the dose-response curve is relatively flat and the adverse effect of prolonged treatment time is of little significance  Patients with sensitive tumours are those who are likely to benefit from radiotherapy  The patients who will be most disadvantaged by prolongation of treatment without compensation will be those whose probability of local control is around 50%.
  • 21.
  • 22. LQ model based iso effective dose calculations. BED =nd* (1 + d/(α/β)) - (ln2 (T - Tk)) / αTp  Tp- Effective Doubling time  Tk- kick of time (tumour repopulation) usually 21-28 days
  • 25. K values- extra dose/day to keep same TCP
  • 27. Gap correction method using BED  Determine remaining no of fractions and dose  Try to Treat patient on weekend days and two fractions daily to finish within the total treatment days planned  Two fraction per day slightly increase late normal tissue toxicity due to incomplete repair.
  • 28. Method of calculation Example 1.  Loss of all of the third week (five fractions) of a treatment schedule of 70 Gy/35 fractions/47 days. 7 weeks  10# treated, 25# remaining.  26 days remaining including weekends.  Treat on next 3 Saturdays and bi-fraction on last two Friday can finish the Tx within the prescribed time.  If bi-fraction treated then at least 6 h gap maintained.
  • 29. Example 2  Loss of all of the sixth week (five fractions) of a treatment schedule of 70 Gy/35 fractions/46 days  25# treated, 10 remaining  Bi-fraction on 6th weekend Saturday  Bi-fraction on last 5 alternate days(Monday-Wednesday and Friday)  The overall treatment time remaining same, with some incomplete repair of normal tissue(bi-fraction)
  • 30.  Example 3  Loss of all of the seventh week (five fractions) of a treatment schedule of 70 Gy/35 fractions/46 days  25# treated. 0 days remaining  Normal tissue BED as prescribed Normal BED =
  • 31. Example 3  Delivered BED before gap  Remaining Normal tissue BED =100-116.7=16.6Gy BED  The tumour BED for prescribed schedule (k=0.9Gy/day, Tdelay-28 days)
  • 32. Example 3  Continue Tx on next 5 days of next week(8th week)  The loss of BED due to repopulation is 7*0.9Gy/day=6.3Gy BED.  So the tumour BED fall of 9%, the Normal tissue BED same.  To make Tumour BED the same as prescribed then,  BED10 (pre-gap) + BED10 (post-gap) – tumor repopulation factor = prescribed BED10  Now total Tx days become 51 days.
  • 33.  New dose per fraction is 2.62Gy.  But the normal tissue BED become 6.7% excess than scheduled. So now make a compromise between TCP and NTCP by trail and error find a dose per fraction, ex: d=2.3Gy then Tumour BED become 3.5% lower and normal tissue BED 3.1% higher.
  • 35. Conclusion  Try to avoid unscheduled gap  Make Departmental protocol to reduce the interruption in Tx  Make the patient category list  Educate patient ‘the importance of daily attendance for Tx’  Use BED based formalism to make calculation by using proper alpha/beta and K values.  The gap correction will be effective once we implement the methods just after the gap occurs.